A Mix of Chlorogenic and Caffeic Acid Reduces C/EBPß and PPAR-γ1 Levels and Counteracts Lipid Accumulation in Macrophages
Overview
Authors
Affiliations
Purpose: Chlorogenic acid (CGA) and caffeic acid (CA) are bioactive compounds in whole grains, berries, apples, some citrus fruits and coffee, which are hypothesized to promote health-beneficial effects on the cardiovascular system. This study aimed to evaluate the capacity of CGA and CA to reduce lipid accumulation in macrophages, recognized as a critical stage in the progression of atherosclerosis. Furtherly, the modulation of CCAAT/enhancer-binding protein β (C/EBPβ) and peroxisome proliferator-activated receptor- γ1 (PPAR-γ1), as transcription factors involved in lipid metabolism, was evaluated.
Methods: THP-1-derived macrophages were treated for 24 h with 0.03, 0.3, 3 and 30 μM of CGA and CA, tested alone or in combination, and a solution of oleic/palmitic acid (500 μM, 2:1 ratio). Lipid storage was assessed spectrophotometrically through fluorescent staining of cells with Nile red. C/EBPβ and PPAR-γ1 mRNA and protein levels were evaluated by RT-PCR and enzyme-linked immunosorbent assay, respectively.
Results: The mix of CGA + CA (1:1 ratio) reduced lipid accumulation at all concentrations tested, except for the highest one. The greatest effect ( - 65%; p < 0.01) was observed at the concentration of 0.3 μM for each compound. The same concentration significantly (p < 0.01) downregulated C/EBPβ and PPAR-γ1 gene expression and reduced their protein levels at 2 h and 24 h, respectively.
Conclusion: The results indicate that the capacity of CGA + CA mix to reduce lipid storage in macrophages is mediated by a reduction in the expression of transcription factors C/EBPβ and PPAR-γ1.
Luo B, Gou Y, Cui H, Yin C, Sun D, Li D Inflammation. 2024; .
PMID: 39215929 DOI: 10.1007/s10753-024-02114-2.
Sheng Y, Hu W, Chen S, Zhu X Front Immunol. 2024; 15:1275203.
PMID: 38779685 PMC: 11109379. DOI: 10.3389/fimmu.2024.1275203.
Zhang Y, Zhang X, Shi S, Ma C, Lin Y, Song W Front Cardiovasc Med. 2024; 11:1372055.
PMID: 38699583 PMC: 11064802. DOI: 10.3389/fcvm.2024.1372055.
Lopez-Parra M, Gomez-Dominguez I, Iriondo-DeHond M, Villamediana Merino E, Sanchez-Martin V, Mendiola J Foods. 2024; 13(7).
PMID: 38611418 PMC: 11011276. DOI: 10.3390/foods13071114.
Berry Dietary Interventions in Metabolic Syndrome: New Insights.
Venturi S, Marino M, Cioffi I, Martini D, Del Bo C, Perna S Nutrients. 2023; 15(8).
PMID: 37111125 PMC: 10142833. DOI: 10.3390/nu15081906.